We report a translational experience of a cardiovascular department facing MACE in COVID-19 patients.
Acute arterial events are the real emergency into this COVID-19 pandemic.
COVID-19 infection may trigger a hypercoagulable status leading to MACE and high mortality rate.
In this COVID-19 outbreak, the adjunct of heparin provides better survival chance independently of the infection-related drug treatment.